logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-22. Secondary drugs cited by clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (i) Outpatient units

Secondary drugNumber of citations by all clients%
Volatile Inhalants8040.3%
Other Substances42871.4%
Hypotics and Sedatives212227.2%
Total number of citations296698100%


 The countries supplying data are: BE, BG, CZ, DK, DE, IE, GR, EE, ES, FR, IT, CY, LV, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, HR, UK. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also 'General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2010 — Table TDI by centre type.  

(see the help page for information about formats etc.)

Page last updated: Thursday, 30 June 2011